TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06273904

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active transcranial focused ultrasound (tFUS)
Description: Active non-invasive low-intensity focused ultrasound will be delivered using a proprietary head-worn device and control software from Attune Neurosciences. On an active stimulation day, focused ultrasound will be delivered to the brain region of interest using parameters from published research that are demonstrated to safely cause temporary changes in the activity in that brain area.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham transcranial focused ultrasound (tFUS)
Description: Non-active low-intensity ultrasound will also be conducted using a proprietary head-worn device and control software from Attune Neurosciences. On the sham stimulation day, the device will be activated in a manner that produces similar sensory effects (i.e., low-volume beeping-type noise from the device) but also prevents delivery of a focused ultrasound beam to the brain area of interest or any other brain area.
Study: NCT04685148

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal patch estradiol
Description: Estradiol patches (200 μg per day by transdermal delivery) will be administered at day 0 (+1) to day 21 postpartum.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Transdermal patch placebo
Description: Placebo patches will be administered at day 0 (+1) to day 21 postpartum.
Study: NCT05524571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Batoclimab
Description: Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo
Study: NCT05377827

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WU-CART-007
Description: Provided by Miltenyi Biotec

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WU-CART-007
Description: Provided by Miltenyi Biotec

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WU-CART-007
Description: Provided by Miltenyi Biotec

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WU-CART-007
Description: Provided by Miltenyi Biotec
Study: NCT04750707

Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxyurea
Description: The study intervention will be daily oral Hydroxyurea given in single doses starting at approximately 20mg/kg/day and escalated to a maximum 30mg/kg/day depending on clinical need and according to standard guidelines.
Study: NCT05981950

Intervention type: DIAGNOSTIC_TEST
Intervention: artificial intelligence algorithm
Description: Retinal diseases diagnosed by artificial intelligence algorithm
Study: NCT06560658

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Participants will receive four 2-hour sessions of supervised microdosing of psilocybin in a two week period.
Study: NCT06636656

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 3032950 intravenous (Part A)
Description: BI 3032950 intravenous (Part A)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 3032950 subcutaneous (Part B)
Description: BI 3032950 subcutaneous (Part B)
Study: NCT06568367

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg
Description: Solriamfetol tablets, taken once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg
Description: Solriamfetol tablets, taken once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets, taken once daily
Study: NCT05587296

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080)
Description: 120 mg elinzanetant orally once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Elinzanetant (BAY3427080)
Description: 120 mg elinzanetant orally once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo orally once daily
Study: NCT05917743

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mat Pilates
Description: Duration: 50 minutes per session Repetitions: 8-12 repetitions per exercise Sets: 2-3 sets per exercise Rests: 30-60 seconds rest between sets Frequency: 3 times per week for 4 weeks Exercises: A series of Mat Pilates exercises targeting core strength, flexibility, and muscle control

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General Exercises
Description: General exercise is a structured exercise program designed to help individuals with back pain improve their fitness levels. The program comprises of a series of exercise classes that are led by a physiotherapist. The classes involve a combination of aerobic, strength, and flexibility exercises, and aim to improve overall physical fitness, reduce pain, and improve function. The program is specifically designed for individuals with back pain, and the exercises are tailored to meet the needs of each participant. The Back to Fitness Program is based on the principles of exercise prescription and is intended to be a safe and effective way to manage back pain through exercise.
Study: NCT06560658

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Participants will receive four 2-hour sessions of supervised microdosing of psilocybin in a two week period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meditation
Description: Participants will receive four 2-hour sessions of supervised microdosing of psilocybin in a two week period. In addition to meditating during their sessions, participants will also meet online five days a week for meditation instruction and practice.
Study: NCT06601140

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMOCARE software
Description: Use of the EMOCARE software on the digital device of participant (smartphone, computer, etc.). The participant can activate and deactivate the software whenever he wishes.
Study: NCT06594926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate
Description: Testosterone enanthate is a depot formulation used in Australia typically for androgen replacement in people with confirmed testosterone deficiency.
Study: NCT06613906

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Healsea Children nasal spray
Description: dosage: 1 puff in each nostril twice daily during 3 treatment periods of 28 days interspersed by 2 wash-out periods of 10 days
Study: NCT05647005

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical music
Description: A total of 15 sessions of music will be applied to this group, two or three days a week, on different days, 3 sessions a day. Sessions will be in the form of listening to classical music for 30 minutes after the babies are fed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Harp music
Description: A total of 15 sessions of music will be applied to this group, two or three days a week, on different days, 3 sessions a day. Sessions will be in the form of listening to harp music for 30 minutes after the babies are fed.
Study: NCT06616532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PM8002
Description: Following a predefined dose and date.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: 175mg/m2 via IV infusion on Day 1 Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175mg/m2 via IV infusion on Day 1 Q3W

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: 1.25mg/m2/day via IV infusion on Days 1-5 Q3W
Study: NCT06669338

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: patients listen to music for 20 minutes with headphones before colonoscopy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: listen to white noise
Description: patients listen to white noise with headphones for 20 minutes before colonoscopy.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: listen to hospital ambient sound
Description: patients listen to recorded ambient sound for 20 minutes with headphones before colonoscopy.
Study: NCT06356805

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: Parallel study: Participants are assigned to one of two groups in parallel for 3 months follow up

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: Parallel study: Participants are assigned to one of two groups in parallel for 3 months follow up
Study: NCT05460208

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enriched spread
Description: The experimental spread is made with a base made with 90% extra virgin olive oil to which plant sterols are added.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control spread
Description: The control spread will be the same base spread made with extra virgin olive oil without the added plant sterols.
Study: NCT06266637

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy Program
Description: Conventional Physical Therapy program:~trunk muscles strengthening exercises, trunk muscles endurance exercises, trunk proprioception exercises . postural correction exercises. Core exercise Spinal mobility exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy Program
Description: Conventional Physical Therapy program:~trunk muscles strengthening exercises, trunk muscles endurance exercises, trunk proprioception exercises . postural correction exercises. Core exercise Spinal mobility exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic Scoliosis-Specific Exercise (Schroth)
Description: It uses exercises customized for each patient to return the curved spine to a more natural position. The spine is addressed in all three anatomical planes - sagittal, frontal and transverse. The purpose of the method is to create spinal balance and stability by improving body mechanics and spinal stabilization to prevent further curve progression
Study: NCT05653908

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: StudentMood
Description: StudentMood is an app that uses ecological momentary assessment method to asses mood and other mental health corelates. Participants will have to complete the application (the mood wheel, heart rate and other behavioral data as well as standardized scales) daily throughout the entire semester
Study: NCT06523790

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brisk walking
Description: Participants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss.
Study: NCT05872399

Intervention type: OTHER
Intervention: Attitudes Towards Psychiatry - 30
Description: The participants will answer their beliefs in 30 statements about psychiatry and mental health.
Study: NCT05159193

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin (PLD)
Description: pegylated liposomal doxorubicin (PLD) 30 mg/m\^2, i.v., d1, q3w
Study: NCT05478746

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioNourish, a component of the Flourish HEC kit
Description: BioNourish is a vaginal moisturizing gel which obtained FDA 510k clearance in 2020. It is one component of the full system being tested. The main intervention is to use this kit to improve the vaginal microbiome.

Intervention type: OTHER
Group type: OTHER
Intervention: Control - no intervention
Description: No intervention; participants only receive routine care.
Study: NCT05159193

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide (C)
Description: cyclophosphamide (C) 600 mg/m\^2, i.v., d1, q3w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab (H)
Description: trastuzumab (H) 8 mg/kg loading dose, 6 mg/kg maintenance doses, i.v., d1, q3w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pertuzumab (P)
Description: pertuzumab (P) 840 mg loading dose, 420 mg maintenance doses, i.v., d1, q3w
Study: NCT05414773

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: measurement of axial length and keratometry by sonographers with a topographic module
Description: measurement of axial length and keratometry by sonographers with a topographic module
Study: NCT06274021

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal stimulation at 100 Hz
Description: Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation method that uses electrical currents to stimulate sensory fibers. The procedure involves placing surface electrodes midline on the lower back (T11-12 spinal processes) and on each side of the belly button. The stimulation frequency during the intervention is 100 Hz, performed at a sub-motor threshold for 30 minutes.
Study: NCT05159193

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel (T)
Description: docetaxel (T) 90\~100 mg/m\^2, i.v., d1, q3w
Study: NCT06274021

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal stimulation at 50 Hz
Description: Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation method that uses electrical currents to stimulate sensory fibers. The procedure involves placing surface electrodes midline on the lower back (T11-12 spinal processes) and on each side of the belly button. The stimulation frequency during the intervention is 50 Hz, performed at a sub-motor threshold for 30 minutes.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal stimulation at 50 Hz and single dose of baclofen
Description: Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation method that uses electrical currents to stimulate sensory fibers. The procedure involves placing surface electrodes midline on the lower back (T11-12 spinal processes) and on each side of the belly button. The stimulation frequency during the intervention is 50 Hz, performed at a sub-motor threshold for 30 minutes.~Study participants will receive a single dose of baclofen, a centrally-acting muscle relaxant belonging to the class of gamma-aminobutyric acid (GABA) analogs. Its primary mechanism involves acting on the GABA receptors in the brain and spinal cord to decrease spasticity. Participants will receive baclofen orally at a single dose of 10 mg.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal stimulation at 50 Hz and single dose of tizanidine
Description: Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation method that uses electrical currents to stimulate sensory fibers. The procedure involves placing surface electrodes midline on the lower back (T11-12 spinal processes) and on each side of the belly button. The stimulation frequency during the intervention is 50 Hz, performed at a sub-motor threshold for 30 minutes.~Study participants will receive a medication called tizanidine, which is an alpha-2 adrenergic agonist. This medication works by inhibiting presynaptic motor neurons, resulting in a reduction of muscle spasticity. It is commonly used to manage spasticity caused by neurological disorders. Each participant will be given a single oral dose of 4 mg of tizanidine as part of this trial.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham transcutaneous spinal stimulation
Description: Sham Transcutaneous spinal stimulation (TSS) involves placing two surface electrodes midline on the lower back (T11-12 spinal processes). The stimulation frequency during the intervention is 50 Hz, performed for 30 minutes.
Study: NCT05132946

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nerve block
Description: unilateral ultrasound-guided erector spinae plane block using bupivacaine 0.25% (on the left side) with total volume 0.5 ml/kg and a maximum dose of 2 mg/kg of bupivacaine in erector spinae plane block group patients
Study: NCT04853290

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral venipuncture
Description: Ultrasound-guided peripheral venipuncture performed by a proficient vascular access registered nurse. The procedure will be performed according to the standard operational protocol for ultrasound guided peripheral venipuncture instituted at the hospital where the study will be conducted. Site Rite 8 or Site Rite 5 ultrasound machines (Bard Access Systems, Inc., USA) will be used on the procedures.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional peripheral venipuncture
Description: Conventional peripheral venipuncture performed by the registered nurse at the clinical inpatient unit. The procedure will be performed according to the standard operational protocol for peripheral venipuncture protocol instituted in the hospital where the study will be conducted
Study: NCT05159193

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel (T)
Description: docetaxel (T) 75 mg/m\^2, i.v., d1, q3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: carboplatin (Cb)
Description: carboplatin (Cb) AUC 6, i.v., d1, q3w
Study: NCT05265676

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin Sodium (Venus Remedies Limited)
Description: The test drug is enoxaparin sodium pre-filled syringe 40 mg/0.4mL of Venus Remedies Limited, India

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin Sodium (Venus Remedies Limited)
Description: The test drug is enoxaparin sodium pre-filled syringe 40 mg/0.4mL of Venus Remedies Limited, India
Study: NCT05159193

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: trastuzumab (H)
Description: trastuzumab (H) 8 mg/kg loading dose, 6 mg/kg maintenance doses, i.v., d1, q3w

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pertuzumab (P)
Description: pertuzumab (P) 840 mg loading dose, 420 mg maintenance doses, i.v., d1, q3w
Study: NCT06012669

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High dose Human Lactoferrin
Description: Dietary Supplement and Food Ingredient
Study: NCT05265676

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin Sodium (Sanofi)
Description: The reference drug is enoxaparin sodium pre-filled syringe 40 mg/0.4mL of Sanofi, Germany

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin Sodium (Sanofi)
Description: The reference drug is enoxaparin sodium pre-filled syringe 40 mg/0.4mL of Sanofi, Germany
Study: NCT06012669

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low dose Human Lactoferrin
Description: Dietary Supplement and Food Ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active Control Bovine Lactoferrin
Description: Dietary Supplement and Food Ingredient
Study: NCT04837560

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ElastiMed's SACS 2.0
Description: A wearable medical device that improve circulation using smart materials
Study: NCT05110066

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary endarterectomy
Description: Surgical pulmonary endarterectomy is done by a thoracic surgical procedure by removing chronic thrombotic material by intimal dissection with patient on cardiopulmonary bypass.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon pulmonary angioplasty
Description: Percutaneous balloon pulmonary angioplasty is performed using standard percutaneous technique to break the fibrotic clots in the pulmonary arteries using percutaneous transluminal angioplasty balloons.
Study: NCT05639764

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oculus Quest 2
Description: A specific immersive virtual reality software designed to address chronic shoulder pain on the Oculus Quest 2 device.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oculus Quest 2
Description: a VRi placebo intervention with the game Tsuro, which consists of a puzzle-based strategy game where the patient will have to solve a maze by placing pieces.
Study: NCT05888116

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hidrante HA
Description: Apply the 5 ml single dose three times a week, every other day, preferably at night before going to bed for 4 weeks.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cumlaude Hidrante Interno®
Description: Apply the 5 ml single dose three times a week, every other day, preferably at night before going to bed for 4 weeks.
Study: NCT05417321

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB0036
Description: Patients will be assigned to dose regimens in the order of enrollment, and they will receive their assigned fixed dose of HB0036 via intravenous infusion. HB0036 IV every 3 weeks (q3w).
Study: NCT05707130

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gaze stabilization exercises
Description: patients will perform gaze stabilization exercise, Static neck exercise, and Habituation exercise. Neck isometric exercises like isometric flexion, extension, lateral bending will be performed.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neck isometrics
Description: Patients in Conventional group will get neck isometric exercises like isometric flexion, extension, lateral bending.
Study: NCT05701735

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CECIL Patient Decision Aid
Description: The CECIL patient decision aid explicitly identifies the disease, the index decision, and the treatment options, describes the positive and negative features and consequences of each option, and guides the patient in examining personal values and preferences, to arrive at a quality and realistic decision.~The decision aid will be developed and validated according to the guidelines and standards published by the International Patient Decision Aids Standards (IPDAS) Collaboration.
Study: NCT05993143

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: Round and white tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Round and white tablets
Study: NCT04934072

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FKS518
Description: Participants will receive FKS518 via subcutaneous injection, every 26 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: US-licensed Prolia
Description: Participants will receive US-licensed Prolia via subcutaneous injection, every 26 weeks.